Skip to main content
ESMC
OTC Industrial Applications And Services

Escalon Swings to $269K Q1 Profit on 38.8% Revenue Growth; Material Weakness Persists

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$0.176
Mkt Cap
$1.308M
52W Low
$0.1
52W High
$0.463
52W Position info
76% above low
Off High info
62% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

ESMC sits 76% above its 52-week low of $0.1 on light trading volume (0.2× avg).

Summary

Escalon posted $269,243 of Q1 FY2027 net income on 38.8% revenue growth to $3.71M, versus a $239,852 loss a year ago, while disclosing that its inventory-valuation material weakness remains unremediated and disclosure controls are still not effective.


Key Events · Earnings and Guidance · ESMC

  • Q1 Swings to Profit

    Net income of $269,243 versus a $239,852 net loss in the quarter ended September 30, 2025; basic and diluted EPS of $0.02.

  • Revenue Up 38.8%

    Net revenue rose to $3,713,612 from $2,675,321, led by a $1,070,000 increase in Sonomed product sales and $76,000 in Trek sales, partly offset by a $108,000 decline in Digital AXIS revenue.

  • Material Weakness Unremediated

    Management concluded disclosure controls are not effective; the material weakness over inventory valuation estimates identified for fiscal 2023 remains, and remedies were insufficient to change the conclusion for fiscal 2026.

  • Cash Builds to $3.67M

    Cash rose to $3,667,758 from $3,065,468 at June 30, 2026, with $603,173 provided by operations; management says liquidity funds operations for the next 12 months.


Analysis · ESMC · Industrial Applications And Services

Escalon flipped from a $239,852 loss to $269,243 of net income as revenue jumped 38.8% to $3.71M, driven by a $1.07M increase in Sonomed product sales. Cash rose to $3.67M, and management says liquidity covers the next 12 months, so the operating trend is genuinely better. Against that, the company still reports an unremediated material weakness over inventory valuation and concludes its disclosure controls are not effective — a governance red flag that keeps a lid on how much the improved quarter can be trusted at face value.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ESMC was trading at $0.18 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $1.3M. The 52-week trading range was $0.10 to $0.46. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ESMC - Latest Insights

ESMC
Oct 13, 2026, 4:00 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $0.165
Real-time Price: $0.1764 info
Change: +$0.0114 (+7%) info
Market Cap: $1.308M info
ESMC
May 15, 2026, 4:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.2507
Real-time Price: $0.1764 info
Change: -$0.0743 (-30%) info
Market Cap: $1.308M info
ESMC
Feb 17, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.1722
Real-time Price: $0.1764 info
Change: +$0.0042 (+2%) info
Market Cap: $1.308M info
ESMC
Jan 29, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.160
Real-time Price: $0.1764 info
Change: +$0.0164 (+10%) info
Market Cap: $1.308M info